Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
30M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
15K
-
Shares change
-
-3.77M
-
Total reported value, excl. options
-
$4.53K
-
Value change
-
-$1.52M
-
Number of sells
-
-35
-
Price
-
$0.30
Significant Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) as of Q2 2025
37 filings reported holding EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share as of Q2 2025.
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15K shares
of 30M outstanding shares and own 0.05% of the company stock.
Largest 10 shareholders include IFP Advisors, Inc (15K shares), HARBOUR INVESTMENTS, INC. (0 shares), Golden State Wealth Management, LLC (0 shares), FNY Investment Advisers, LLC (0 shares), VISION FINANCIAL MARKETS LLC (0 shares), Eukles Asset Management (0 shares), Tradewinds Capital Management, LLC (0 shares), Allworth Financial LP (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), and Compagnie Lombard Odier SCmA (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.